Telemedicine for ADHD: What You Need to KnowAsk The Expert

 September 21, 2022 8:00 PM - 9:00 PM EDT

Max Wiznitzer MD

Telemedicine or telehealth is a relatively new service or private practice approach that offers evaluations for children and adults with ADHD. Telemedicine services can be cost-effective and a convenient alternative to an in-person visit with a doctor or specialist. The key is finding the right fit for you or your family. If you’re thinking about using a telehealth service, there are some things you must know. In this webinar, Dr. Max Wiznitzer presents information that will be helpful to parents, adults with ADHD, and mental health professionals.


Upon completion of this webinar, you will understand:

  • the advantages and disadvantages of telemedicine
  • how to find a reputable provider
  • the elements of a comprehensive evaluation for ADHD and coexisting disorders
  • what questions to ask your health insurance company before the first appointment
  • ways to receive and manage prescriptions
  • how to request referrals

About the Presenter

Max Wiznitzer, MD, is a graduate of Northwestern University School of Medicine. He trained in pediatrics and developmental disorders at Cincinnati Children’s Hospital and in pediatric neurology at Children’s Hospital of Philadelphia. He then did a National Institutes of Health funded fellowship in disorders of higher cortical functioning in children at the Albert Einstein College of Medicine, Bronx, New York. Since 1986, Dr. Wiznitzer has been a pediatric neurologist at Rainbow Babies & Children’s Hospital in Cleveland, Ohio. He is an associate professor of pediatrics, neurology, and international health at Case Western Reserve University. He has a longstanding interest in neurodevelopmental disabilities, especially ADHD and autism, and has been involved in local, state, and national committees and initiatives, including autism treatment research, Ohio autism service guidelines, autism screening, and early identification of developmental disabilities. He is on the editorial board of Lancet Neurology and the Journal of Child Neurology and lectures nationally and internationally about various neurodevelopmental disabilities.

This webinar is provided by CHADD’s National Resource Center on ADHD and is supported by Cooperative Agreement Number NU38DD005376 funded by the Centers for Disease Control and Prevention (CDC).

For questions, please email